The financing was led by Mellby Gård with strong support from AMF, Ramsbury and existing shareholders, alongside new investors.

Under the terms of the agreement, CSPC will receive an upfront payment of USD 110 million. @AstraZeneca

Introducing Grok Imagine.

This initiative by @EU_Commission focused first on the science component promoting a unified European approach to attract and retain talent, thereby strengthening Europe’s competitiveness.

RT @LIFse: Bara hälften av nya läkemedel i EU når svenska patienter. Av 173 läkemedel som godkändes av europeiska läkemedelsmyndigheten EMA….

This collaboration represents a powerful alignment of capabilities designed to address the growing complexity of global regulatory requirements, the companies state. @RecipharmAB

The first study in the US aims to verify the pharmacokinetic profile of a new formulation of AQ280 specifically developed for the treatment of patients with EoE (eosinophilic esophagitis).

"We believe investors in Sweden, and more broadly in the Nordics and continental Europe, will find Alvotech highly attractive, with a strong and differentiated value proposition," says Róbert Wessman @alvotechpr

For the first time @novonordiskfond is inviting researchers from outside Denmark, in the European Schengen area, Cyprus, Ireland and the UK, to lead collaborations applying for grants to study four major themes.

#AAXBiotechAB has announced a new collaboration focused on developing antibody-based therapies for acute and critical care of cardiovascular disease.

The investments not only enhance @HealthCapVC ability to support transformative healthcare companies but also reinforce the Nordic region’s position as a global leader in life science innovation and entrepreneurship," says Mårten Steen, Managing Partner

"We are pleased with the CHMP’s positive recommendation for market authorization for Oczyesa octreotide monthly depot for the treatment of acromegaly," says Fredrik Tiberg, Camurus

"We are interested in identifying new targets for interventions that could then be used to develop new drugs and vaccines or help us understand why some mosquito species transmit malaria while others do not." @umeauniversitet #WorldMalariaDay2025

"To be able to control costs and serve patients, the world will need biosimilars," says Róbert Wessman, Icelandic businessman and entrepreneur @alvotechpr

The Board @Biotage has decided to recommend that Biotage shareholders accept the offer. @KKR_Co

"The EU has a choice to make. Either we act and secure Europe’s position as a leading region for research and innovation, or we watch as others take the lead," says Sofia Wallström, CEO @LIFse

This is the first therapy targeting an underlying cause of Alzheimer’s disease (AD) to be granted an MA in the EU. @bioarcticab

The map is designed to provide patients and healthcare professionals with easy access to comprehensive, real-time information about clinical trials conducted in their area, increasing access to clinical research in the EU.

TIRmed Pharma has raised financing in a funding round led by @sciety_info and Sciety Venture Partners.

Even though many have tried and few succeeded in the quest to find viable treatments for neurodegenerative diseases, Nordic drug developers continue to take different approaches to crack the riddle. @Alzinova @PolkuTx

"Production costs will increase even for American pharmaceutical companies, as the tariffs will disrupt supply chains for critical raw materials, packaging, and consumables needed to manufacture medicines," says Jessica Martinsson @SwedenBIO